Key result
High fear of cancer recurrence was reported by 35% of partners of prostate cancer survivors, comparable to the 38% reported by the survivors themselves (P = .542).
Population
168 partners of disease-free prostate cancer survivors
Design
Cross-sectional
Authors
Loading...
Partners report comparable high fear of recurrence; hypothesis-generating for dyadic screening and support in survivorship care.
Cross-Sectional (n=168)
Absolute Event Rate: 35% vs 38%
p-value: p=.542
Fear of cancer recurrence is a significant concern for partners of prostate cancer survivors, negatively impacting their health-related quality of life.
Wal et al. (2017) conducted a cross-sectional in Fear of cancer recurrence in partners of prostate cancer survivors (n=168). Partner of a prostate cancer survivor vs. Prostate cancer survivor was evaluated on High fear of cancer recurrence (p=.542). High fear of cancer recurrence was reported by 35% of partners of prostate cancer survivors, comparable to the 38% reported by the survivors themselves (P = .542).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: